Literature DB >> 15792133

Renal variant of Anderson-Fabry disease and bilateral renal cell carcinoma.

Julia Blanco1, José Herrero, Luis F Arias, Noemí Garcia-Miralles, Carmen Gamez, Alberto Barrientos.   

Abstract

Anderson-Fabry disease (AFd) is an X-linked metabolic disease with clinical manifestations secondary to accumulation of glycosphingolipids in various tissues. We report the first case in which a patient with renal variant of AFd and chronic renal failure developed bilateral conventional renal cell carcinoma. His metabolic disorder was diagnosed only after histopathologic study of the kidney specimen resected because of the tumoral lesion. There is no clear etiologic relation between the metabolic and neoplastic disease. As AFd is not common or well known and its clinical manifestations tend to be nonspecific, the disorder is often unrecognized, misdiagnosed, or diagnosed late in life. The pathologist should be aware of this disorder when evaluating a kidney specimen from patients with chronic renal failure of unknown cause.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15792133     DOI: 10.1016/j.prp.2004.09.003

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  5 in total

1.  Bilateral renal cell carcinoma development in long-term Fabry disease.

Authors:  D Cassiman; K Claes; E Lerut; R Oyen; S Joniau; B Van Damme; J Jaeken
Journal:  J Inherit Metab Dis       Date:  2007-05-12       Impact factor: 4.982

Review 2.  Insights into the pathogenesis and treatment of cancer from inborn errors of metabolism.

Authors:  Ayelet Erez; Oleg A Shchelochkov; Sharon E Plon; Fernando Scaglia; Brendan Lee
Journal:  Am J Hum Genet       Date:  2011-04-08       Impact factor: 11.025

3.  Fabry disease and incidence of cancer.

Authors:  Sarah Bird; Efthymios Hadjimichael; Atul Mehta; Uma Ramaswami; Derralynn Hughes
Journal:  Orphanet J Rare Dis       Date:  2017-09-06       Impact factor: 4.123

4.  Fabry disease: Four case reports of meningioma and a review of the literature on other malignancies.

Authors:  Beth L Thurberg; Dominique P Germain; Fernando Perretta; Iulia E Jurca-Simina; Juan M Politei
Journal:  Mol Genet Metab Rep       Date:  2016-10-01

Review 5.  Potential Role of Sphingolipidoses-Associated Lysosphingolipids in Cancer.

Authors:  Patricia Dubot; Leonardo Astudillo; Nicole Therville; Lorry Carrié; Magali Pettazzoni; David Cheillan; Jérôme Stirnemann; Thierry Levade; Nathalie Andrieu-Abadie; Frédérique Sabourdy
Journal:  Cancers (Basel)       Date:  2022-10-05       Impact factor: 6.575

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.